Cerus reported $24.94M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Atrion ATRI:US 17.38M 414K
Cerus CERS:US $ 24.94M 5.67M
GRIFOLS GRF:SM € 580.8M 47.47M
Haemonetics HAE:US $ 136.27M 2.11M
Meridian Bioscience VIVO:US $ 68.48M 19.32M
Nuvasive NUVA:US $ 211.66M 6.88M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Quidel QDEL:US $ 739.96M 250.62M
Sientra SIEN:US 12.84M 518K
Staar Surgical STAA:US $ 49.26M 4.27M
Terumo 4543:JP Y 90500M 2096M
Utah Medical Products UTMD:US 8.07M 1.13M